Glen Tullman
CEO and Founder @ Transcarent
Golden, United States
Glen Tullman is a Series B investor at Transcarent in Golden focused on Health Care and Medical. Glen Tullman is based out of Chicago, Illinois and is the CEO and Founder of Transcarent. He previously worked at Livongo as a Co-Founder and Executive Chairman. Glen Tullman attended the University of Oxford.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 47%
Last updated:
For AI agents: llms.txt
Industries Glen Tullman invests in
Stages Glen Tullman invests in
Countries Glen Tullman invests in
Investment Focus
Industry
- Health Care 8 (47%)
- Medical 3 (18%)
- Health Diagnostics 3 (18%)
- Wellness 2 (12%)
- Elder Care 2 (12%)
Stage
- Series B 6 (35%)
- Seed 2 (12%)
- Series A 2 (12%)
- Series C 1 (6%)
- Funding Round 1 (6%)
Country
- United States 9 (53%)
- India 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Homethrive
|
Homethrive provides care management and personal assistance services to help older adults live at home with dignity and purpose while reducing the stress, strain, work, and worry for their family members. | $20M / Series B / Nov 14, 2024 | |
PeopleOne Health
|
PeopleOne Health provides world-class healthcare that seamlessly blends treatment and prevention, leading to significant savings for employers and employees by keeping people healthier. This is the next generation of value-based primary care. Employers save up to 30% on healthcare costs and enhance employee recruiting and retention. Employees getaccess to an award-winning health benefit at no cost, including a team of top-tier doctors and healthcare professionals. Leading employers and thousands of members trust PeopleOne Health and rate their customer satisfaction an excellent 90+ NPS (exceeding the healthcare industry average of 35). Discover more at peopleonehealth.com. | $32.3M / Series B / Oct 24, 2024 | |
9amHealth
|
9amHealth is a virtual healthcare company focused on managing chronic cardiometabolic conditions such as diabetes, obesity, high blood pressure, and high cholesterol. The platform connects patients with licensed healthcare providers, pharmacists, nutritionists, prescription delivery services, and at-home laboratory testing through a digital caremodel. Its services include personalized treatment plans, medication management, ongoing monitoring, and remote consultations designed to support long-term condition management. The company also works with employers, health plans, and pharmacy benefit managers to provide healthcare support programs for individuals living with chronic illnesses. 9am.health’s care approach combines medical treatment, behavioral support, and digital tools to help patients access healthcare services remotely and manage their conditions more consistently. | $9.5M / Series A / Feb 19, 2024 | |
Khyaal
|
Khyaal is a full-stack digital solution for senior citizens designed and developed to improve their quality of life. We facilitate on-demand services and organise fun and engaging activities for seniors. Being a part of the Khyaal family means making a difference in the world by enriching the lives of the elderly. If selflessness and empathy is atrait that you carry and would want to put at work, then you will find Khyaal as the perfect place to invest your valuable time.At Khyaal, we value your individuality and the skills that you bring to the table. We also believe in the power of collective consciousness to serve others and make their lives easier and wholesome. We want all members of the Khyaal family to feel respected personally and professionally. Our working environment will always make way for new ideas, ownership and collective growth. | $4.2M / Seed / Feb 06, 2024 | |
|
Khyaal
|
Khyaal is a full-stack digital solution for senior citizens designed and developed to improve their quality of life. We facilitate on-demand services and organise fun and engaging activities for seniors. Being a part of the Khyaal family means making a difference in the world by enriching the lives of the elderly. If selflessness and empathy is atrait that you carry and would want to put at work, then you will find Khyaal as the perfect place to invest your valuable time.At Khyaal, we value your individuality and the skills that you bring to the table. We also believe in the power of collective consciousness to serve others and make their lives easier and wholesome. We want all members of the Khyaal family to feel respected personally and professionally. Our working environment will always make way for new ideas, ownership and collective growth. | $4.2M / Seed / Feb 06, 2024 | |
NOCD
|
NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better. With NOCD, users can have face-to-face video therapy sessions with licensed therapists that specialize in OCD, as well as get 24/7 support between sessions from self-help tools and peer communities. | $34M / Series B / Jan 31, 2023 | |
Homeward
|
Homeward is rearchitecting rural health and care for the 60 million Americans living in rural communities. Homeward employs a multidisciplinary care team, available both virtually and on the ground via mobile care units, with in-home remote monitoring to better connect patients to high-quality, affordable, and comprehensive care. Today, the companypartners with Medicare Advantage plans, taking on the full risk of their members to improve outcomes and reduce costs. | $50M / Series B / Aug 03, 2022 | |
|
Homethrive
|
Homethrive provides care management and personal assistance services to help older adults live at home with dignity and purpose while reducing the stress, strain, work, and worry for their family members. | $20M / Series B / May 20, 2022 | |
|
9amHealth
|
9amHealth is a virtual healthcare company focused on managing chronic cardiometabolic conditions such as diabetes, obesity, high blood pressure, and high cholesterol. The platform connects patients with licensed healthcare providers, pharmacists, nutritionists, prescription delivery services, and at-home laboratory testing through a digital caremodel. Its services include personalized treatment plans, medication management, ongoing monitoring, and remote consultations designed to support long-term condition management. The company also works with employers, health plans, and pharmacy benefit managers to provide healthcare support programs for individuals living with chronic illnesses. 9am.health’s care approach combines medical treatment, behavioral support, and digital tools to help patients access healthcare services remotely and manage their conditions more consistently. | $16M / Series A / Apr 13, 2022 | |
Alinea Health
|
Alinea Health provides solution for corporate health. | $3.9M / Venture - Series Unknown / Mar 16, 2022 | |
| See all 17 investments → | |||
Co-Investors
Everywhere Ventures
6 deals together
Human Capital
6 deals together
Founders Fund
4 deals together
General Catalyst
4 deals together
Cigna Ventures
3 deals together
Health Enterprise Partners
3 deals together
About Transcarent
Transcarent is a consumer-directed health and care platform for employees of self-insured employers and their families. Using a combination of software, technology, health guides, and data science, the company helps consumers with unbiased information, trusted guidance, and access to high-value care.
Transcarent Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Glen Tullman
CEO and Founder
|
|||
Caitlin Fleming
Chief of Staff
|
|||
Jeff Dobro
Chief Innovation Officer
|
|||
John Hallock
SVP Communication
|
|||
Maniesh Joshi
Director, Product Marketing
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Glen Tullman invest in?
Glen Tullman invests primarily in Health Care, Medical and Health Diagnostics startups, most often at Series B and Seed stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Glen Tullman last invest?
The most recent investment recorded for Glen Tullman closed in Nov 2024. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
